Salarius Pharmaceuticals, Inc. financial data

Symbol
SLRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2450 Holcombe Blvd, Suite J 608, Houston, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
Flex Pharma, Inc. (to 7/22/2019)
Latest financial report
10-K - Q4 2024 - Mar 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 46.4 % +0.11%
Return On Equity -213 % -7.7%
Return On Assets -146 % -7.66%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.75M shares -63.5%
Common Stock, Shares, Outstanding 1.44M shares +193%
Entity Public Float 1.5M USD -69.5%
Common Stock, Value, Issued 144 USD +194%
Weighted Average Number of Shares Outstanding, Basic 962K shares +136%
Weighted Average Number of Shares Outstanding, Diluted 962K shares +136%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 770K USD -89.3%
General and Administrative Expense 4.96M USD -13.2%
Operating Income (Loss) -5.73M USD +55.5%
Net Income (Loss) Attributable to Parent -5.58M USD +55.5%
Earnings Per Share, Basic -5.79 USD/shares +81.2%
Earnings Per Share, Diluted -5.79 USD/shares +81.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.43M USD -58.7%
Other Assets, Current 43.7K USD -71.1%
Assets, Current 2.99M USD -54.2%
Other Assets, Noncurrent 35.4K USD -47%
Assets 3.02M USD -54.1%
Accounts Payable, Current 937K USD +55.4%
Liabilities 1.51M USD +16.3%
Retained Earnings (Accumulated Deficit) -81.9M USD -7.3%
Stockholders' Equity Attributable to Parent 1.51M USD -71.4%
Liabilities and Equity 3.02M USD -54.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.35M USD +57.3%
Net Cash Provided by (Used in) Financing Activities -173K USD -151%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 1.44M shares +193%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.53M USD +46.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.43M USD -58.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.02K USD
Deferred Tax Assets, Valuation Allowance 17.1M USD +7.54%
Deferred Tax Assets, Gross 17.1M USD +7.54%
Deferred Tax Assets, Operating Loss Carryforwards 8.35M USD +35.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 83.4M USD +2.21%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.11K USD -33.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%